SG Americas Securities
APLT

SG Americas Securities’s Applied Therapeutics APLT Stock Holding History

SG Americas Securities’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-41,748
Closed -$4K – 3203
2025
Q4 		$4K Buy
41,748
+25,344
+154% +$16.1K ﹤0.01% 3543
2025
Q3 		$10K Sell
16,404
-7,131
-30% -$3.36K ﹤0.01% 3321
2025
Q2 		$7K Buy
23,535
+9,637
+69% +$3.73K ﹤0.01% 2863
2025
Q1 		$7K Sell
13,898
-26,849
-66% -$15.8K ﹤0.01% 3417
2024
Q4 		$35K Buy
40,747
+25,601
+169% +$160K ﹤0.01% 2962
2024
Q3 		$129K Sell
15,146
-3,421
-18% -$20.2K ﹤0.01% 2845
2024
Q2 		$87K Buy
+18,567
New +$87.9K ﹤0.01% 2579
2021
Q4 		– Sell
-9,202
Closed -$153K – 3362
2021
Q3 		$153K Buy
+9,202
New +$159K ﹤0.01% 3419
2020
Q3 		– Sell
-3,592
Closed -$130K – 2688
2020
Q2 		$130K Buy
+3,592
New +$150K ﹤0.01% 3188

SG Americas Securities's APLT Position: Q1 2026 in Review

SG Americas Securities sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 41,748 shares — an estimated $4K sold.

SG Americas Securities first reported a position in APLT in Q2 2020 and held it in 9 quarters. The position peaked at $153K in Q3 2021. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

  • SG Americas Securities reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
  • SG Americas Securities sold 41,748 Applied Therapeutics shares in Q1 2026, an estimated $4K.
  • SG Americas Securities first reported a position in Applied Therapeutics in Q2 2020 and held it in 9 quarters.
  • SG Americas Securities's Applied Therapeutics position peaked at $153K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.